Top Companies in the Clinical Trial Supplies Market
- Catalent Pharma Solutions
- Thermo Fisher Scientific
- PCI Pharma Services
- Marken (UPS Healthcare / Marken Logistics)
- Almac Group
- Vetter Pharma
- Lonza
- Recipharm
- Parexel Supply & Logistics (Parexel International)
- IQVIA
- Clinigen Group
- DHL Life Sciences & Healthcare
- Jubilant HollisterStier / Jubilant Pharma Services
- Movianto (part of Agility)
- PCI / others (regional CMOs) - e.g., Sharp (CMO partners) & local specialists
- Kuehne + Nagel
- FedEx / FedEx Clinical Solutions
- Siegfried Holding AG / specialized CMO-CTS divisions
- Local & regional specialist CTS providers/depot operators
Market Forecast
The global clinical trial supplies market size reached US$ 4.9 billion in 2024 and is anticipate to increase to US$ 5.34 billion in 2025. By 2034, the market is forecasted to achieve a value of around US$ 11.4 billion, growing at a CAGR of 8.87%.
Clinical Trial Supplies Market Trends
- Increasing Collaboration: In July 2025, Auriga Research Pvt. Ltd. announced a strategic Memorandum of Understanding (MoU) with the San Francisco Research Institute (SFRI) to synergise the core competencies of both organizations, such as strengthening AI-integrated clinical research, streamlining regulatory pathways, and expediting the development and market access of healthcare products across India, North America, and Africa.
- Favorable Government Support: In May 2025, the European Union (EU) launched new clinical trial regulations to improve efficiency and offer streamlined processes and transparency. The EU has also launched a unified portal, Clinical Trials Information System (CTIS) regulatory platform for submitting and managing trial data.
Value Chain Analysis in the Clinical Trial Supplies Market
R&D
Academic institutions and pharmaceutical companies conduct research activities to develop novel diagnostics and therapeutics, such as drugs, biologics, and medical devices, for numerous disorders.
Key Players: Novartis, AstraZeneca, Merck, and Biogen
Clinical Trials & Regulatory Approvals
Clinical trial supplies require regulatory approvals to ensure they are handled according to strict guidelines. They involve the secure and compliant management of IMPs used in clinical research.
Key Players: IQVIA, Parexel International, Cencora, and Proventa International
Patient Support & Services
Clinical trial supplies provide patient support & services by delivering the right products to the right patients and at the right time to conduct clinical trials, safely and effectively.
Key Players: ICON plc, McKesson, and Pantheon Pharma Services
Latest Announcement by Industry Leaders
Sean P. Bohen, President and Chief Executive Officer of Olema Oncology, commented that the company can initiate its planned pivotal Phase 3 clinical trial, OPERA-02, for palazestrant in combination with ribociclib in frontline ER+/HER2- metastatic breast cancer. He also said that the new agreement with Novartis is a major milestone, which includes sufficient ribociclib drug supply for the planned approximately 1,000-patient trial.
Recent Developments in the Clinical Trial Supplies Market
- In January 2025, Ancillare announced the launch of its state-of-the-art cold chain management services to ensure safe handling and transport of temperature-sensitive supplies and equipment in clinical trials. Ancillare aims to maintain precise refrigerated temperatures throughout the entire supply chain.
- In January 2025, Suvoda announced a merger with Greenphire to create a more seamless clinical trial experience for patients, sites, and sponsors. The merger will provide market-leading offerings to create an end-to-end platform to help bring medicines to those who need them most.
Become a valued research partner with us, please feel free to contact us at sales@towardshealthcare.com
